Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm
11/06/2018
Belinchon I, Ramos JM, Carretero G, Ferrandiz C, Rivera R, Dauden E, et al.
Descargar documento
J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1700-8. PMID: 28485816